{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-033507","form_type":"8-K","ticker":"RAPH","cik":"0001415397","company_name":"Raphael Pharmaceutical Inc.","filed_at":"2026-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.030042+00:00","generated_at":"2026-05-15T09:11:11.686142+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Director Yehuda Eliya term expires, leaves Raphael board effective Dec 31, 2025","bullets":["Dr. Yehuda Eliya's board term expired Dec 31, 2025; ceased serving as director.","Departure not related to any disagreement with company operations, policies, or practices.","No replacement director announced as of filing date March 24, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-033507","json":"https://secwatch.observer/filing/0001213900-26-033507.json","markdown":"https://secwatch.observer/filing/0001213900-26-033507.md","text":"https://secwatch.observer/filing/0001213900-26-033507.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1415397/000121390026033507/0001213900-26-033507-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1415397/000121390026033507/ea0283251-8k_raphael.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:11:11.686142+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}